Hundreds of thousands of Spanish women have spent months encountering problems getting hold of some of the hormone treatments used to relieve menopausal symptoms.
What began as an issue with a single medicine — Lenzetto, a transdermal estradiol spray — has finally triggered a domino effect in the market for hormone replacement therapies (HRT).
